<html>
<head>PUBMED IDs for OY-TES-1</head>
<body bgcolor='#C5F0F2'><h1>OY-TES-1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11248070/'>Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.</a> March 15  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/25673160/'>OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: a bioinformatic analysis combine with RNAi and oligonucleotide microarray.</a> January 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26339343/'>Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26339341/'>Knockdown of Gli1 by small-interfering RNA enhances the effects of BCNU on the proliferation and apoptosis of glioma U251 cells.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26339340/'>Bone marrow mesenchymal stem cells protect against bleomycin-induced pulmonary fibrosis in rat by activating Nrf2 signaling.</a> December 15  2015<br></body></html>
